GLPG / GILD: The company said they couldn't comment on P3 trial till Gilead goes ahead... and then these appear today Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis https://clinicaltrials.gov/ct2/show/NCT02914522 Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis https://clinicaltrials.gov/ct2/show/NCT02914535 Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease https://clinicaltrials.gov/ct2/show/NCT02914561 Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease https://clinicaltrials.gov/ct2/show/NCT02914600